Medical Device Translational Research Projects
Objective
The mission of California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world.
The objective of this initiative is to create a highly competitive opportunity for promising regenerative medicine (stem cell-based or gene therapy) projects that accelerate completion of translational stage activities necessary for advancement to clinical study or broad end use for any one of the following product types:
- TRAN 1: Stem cell-based or gene therapy therapeutic candidate
- TRAN 2: Diagnostic (including medical imaging agents) based on stem cells, or critical for stem cell-based or gene therapy development or use
- TRAN 3: Medical device (non-diagnostic) for a stem cell-based therapy or critical for stem cell-based or gene therapy development or use
- TRAN 4: Novel tool that addresses a critical bottleneck to the discovery or development of stem cell-based or gene therapy
Please see our Funding Opportunities page for more details
ICOC Approval:
April 19, 2022
Total Awards:
1
Award Value:
$3,082,579
Awards
| Institution | Investigator | Grant Title | Award Value |
|---|---|---|---|
| University of California, Davis | Aijun Wang PhD | Living Synthetic Vascular Grafts with Renewable Endothelium | $3,082,579 |
| Total: $3,082,579.00 |